Stem cells in cancer therapy: opportunities and challenges

Area of Science:

• Oncology
• Regenerative Medicine
• Biotechnology

Background:

• Metastatic cancer is difficult to eradicate with conventional treatments, leading to frequent recurrence.
• Stem cell therapies are emerging as a promising alternative for cancer treatment.
• Stem cells can be engineered for targeted drug delivery and other therapeutic applications.

Purpose of the Study:

• To review recent advancements in stem cell-based cancer treatments.
• To summarize the advantages, opportunities, and limitations of these therapies.
• To guide future clinical trials and research.

Main Methods:

• Review of preclinical animal models using engineered stem cells.
• Analysis of stem cells as delivery platforms for cytotoxic agents, viruses, and nanoparticles.
• Exploration of stem cell applications in regenerative medicine, immunotherapy, and drug screening.

Main Results:

• Engineered stem cells have shown efficacy in reducing tumor volumes and extending survival in preclinical models.
• Stem cells serve as effective carriers for targeted therapies, enhancing efficacy and reducing side effects.
• Stem cells have diverse applications including regenerative medicine, immunotherapy, and drug screening.

Conclusions:

• Stem cell-based cancer therapy is technically feasible but requires further investigation into treatment durability and tumorigenesis.
• Continued research is essential to optimize therapeutic performance and clinical applicability.
• This review provides insights for refining stem cell cancer trials and facilitating clinical translation.